The HPV16 E7 oncoprotein neutralizes several cell cycle checkpoints, favouring the entry of quiescent cells into S phase. This activity is mediated in part by association of E7 with the pocket proteins and consequent activation of E2F transcription factors. In addition, HPV16 E7 protein is able to promote apoptosis. In this study we demonstrate that the ability to induce apoptosis is a common property of E7s belonging to both benign and malignant HPV types. The E7-induced apoptosis is mediated by inactivation of pRb, whilst neutralization of the other two pRB-related proteins, p107 and 130, is not sucient to trigger apoptosis. Moreover, we show that certain point mutations in the conserved region 1 (CR1) of HPV16 E7 abolish the induction of apoptosis without altering the ability to stimulate S phase. Thus, these two E7-mediated cellular events, apoptosis and S phase entry, can be separated in immortalized rodent ®broblasts. Our ®ndings demonstrate that the E7-mediated pRb destabilization is not required for its ability to drive quiescent cells into S phase and to induce apoptosis. Finally, expression of E7 proteins in NIH3T3, which lack a functional p19 ARF , does not lead to p53 accumulation, indicating that the E7 impacts upon additional cellular pathways to promote apoptosis.
Introduction
Certain Human Papillomaviruses (HPV) genotypes have been clearly associated with cervical cancer. HPV16 is the most frequently found genotype in malignant lesions, being present in approximately 50% of the cases. Several lines of evidence indicate that the products of two early genes, E6 and E7, play a key role in the induction of malignant transformation of the host cells (reviewed by Mansur and Androphy, 1993; Tommasino and Crawford, 1995) . The HPV16 E7 protein is able to induce focus formation and growth in soft agar in a variety of established rodent ®broblast lines and to co-operate with E6 to immortalize primary human keratinocytes (reviewed by Mansur and Androphy, 1993) . These activities are in part explained by the ability of E7 to interact with and to induce destabilization of the so-called`pocket' proteins, pRb, p107 and p130 (Dyson et al., 1989; Davies et al., 1993; Hu et al., 1995; Boyer et al., 1996; . The pocket proteins are central regulators of cell cycle division. They negatively regulate, via direct association, the activity of several transcription factors, including members of E2F family (E2F1-5) (reviewed by Kouzarides, 1995) . Under normal cell cycle regulation, phosphorylation of pRb, which is mediated by cyclin-dependent kinase (CDK) activity leads to the disruption of pRb/E2F complexes, with consequent activation of E2Fs (Nevins, 1998) . HPV16 E7 binds the pocket proteins and, analogously to the CDK-mediated phosphorylation, results in the release of active E2Fs which in turn activate transcription of a group of genes encoding proteins essential for S phase progression (reviewed by Tommasino and Crawford, 1995) .
As other stimulators of proliferation, the HPV16 E7 protein, besides the ability to deregulate the cell cycle, promotes apoptosis (Pan and Griep, 1994, 1995; White et al., 1994; Puthenveettil et al., 1996; Iglesias et al., 1998; Stoppler et al., 1998) . Expression of HPV16 E7 in normal human ®broblasts (NHF) or in human keratinocytes results in a cytocidal response, which is much more evident in the absence of mitogenic signals and displays the typical features of apoptosis . Although the ability of E7 to induce apoptosis has been demonstrated in dierent cell types and experimental systems, the signals that are triggered by E7 in the induction of apoptosis are not well de®ned. Experiments with E7 CR2 deletion mutants, which are not able to associate with pRb, p107 and p130, provide evidence that the inactivation of pocket proteins is an essential requirement for the E7-induced apoptosis (Pan and Griep, 1994; . However it is not clear yet whether the E7-induced apoptosis is triggered by inactivation of one or more members of the pocket proteins.
HPV16 E7 is structurally and functionally related to adenovirus E1A (Phelps et al., 1988) . Both viral proteins induce stabilization and accumulation of the transcription factor p53 (Debbas and White, 1993; Demers et al., 1994; Hickman et al., 1994; Lowe and Ruley, 1993; Querido et al., 1997; Samuelson and Lowe, 1997; Slebos et al., 1994) . Studies on Adenovirus E1A demonstrate that p53 stabilization is mediated by the activation of E2F-1, which in turn stimulates the transcription of the tumour suppressor p19 ARF gene . p19
ARF associates with and inhibits Mdm2 (Kamijo et al., 1998; Pomerantz et al., 1998; Stott et al., 1998; Zhang et al., 1998) , which acts in a feedback loop to antagonize p53 function by direct binding (Barak et al., 1993; Wu et al., 1993) . Mdm2 association with p53 inhibits p53 transcriptional activity (Momand et al., 1992; Oliner et al., 1993) , induces p53 ubiquitination (Haupt et al., 1997; Honda et al., 1997; Kubbutat et al., 1997) and accelerates p53 nuclear export and its degradation in cytoplasmic proteosomes (Roth et al., 1998) . Consistent with these ®ndings, the E1A-induced apoptosis appears to be dependent on p53-mediated pathways (Debbas and White, 1993; Lowe and Ruley, 1993; Querido et al., 1997; Samuelson and Lowe, 1997) . Also in the case of HPV16 E7 the induction of apoptosis is dependent on p53. In fact, HPV16 E7 protein sensitizes immortalized human uroepithelial cells to apoptosis in response to gamma radiation only in the presence of a functional p53 (Puthenveettil et al., 1996) . However, a study in transgenic mice expressing E7 in the eyes showed that also p53 independent pathways mediate the E7-induced apoptosis (Pan and Griep, 1995) .
To further characterize the cellular mechanisms involved in the E7-induced apoptosis, we have analysed in rodent ®broblasts the properties of several E7 proteins, including E7s from dierent HPV types as well as HPV16 E7 mutants. We show that association of HPV16 E7 with pRb is an essential requirement to promote apoptosis, since the inactivation of p107 and p130 is not sucient to induce this cellular event. However, the E7-mediated pRb destabilization does not play a role in promoting either apoptosis or S phase. Most importantly, our data demonstrate that in immortalized rodent ®broblasts, which lack a functional p19 ARF , the E7-induced apoptosis can be separated from the DNA synthesis stimulation.
Results
In order to elucidate the mechanisms by which E7 induces apoptosis, we have analysed the ability of three dierent E7s from benign (HPV1 and 6) and malignant (HPV16) HPV types to stimulate cell death in immortalized rodent ®broblasts, NIH3T3. As indicated in Table  1 , E7 proteins from these three HPV types dier in their in vitro transforming activity and in their anity for binding pocket proteins. The E7 genes from HPV1, 6 and 16 were expressed in the retroviral vector pBabe-puro (Morgenstern and Land, 1990) . To compare the level of expression of the viral genes the haemagglutinin tag (HA) was fused in frame at the N-terminal of each E7 gene ( Figure 1 ). As shown in Figure 2a , similar levels of HA-E7 proteins were detected in NIH3T3 cells infected with E7 recombinant retroviruses. The dierent electrophoretic mobility of the fusion proteins is not dependent on the presence of the HA domain, but it is an intrinsic feature of the native E7 proteins (Armstrong and Roman, 1993). Next we determined the ability of the E7 proteins to trigger apoptosis. Analogously to other inducers of apoptosis, such as c-myc, Adenovirus E1A or E2F-1 (Evan et al., 1992; Hsieh et al., 1997; White et al., 1994) , E7-induced apoptosis is more pronounced when the cells are deprived of serum survival factors . Therefore, NIH3T3 cells expressing the dierent E7 genes were cultured in medium containing 0.5% calf serum and the percentage of apoptotic cells was determined using time-lapse videomicroscopy. Under this condition, we observed that the three HAE7s induce dierent levels of cell death (Figure 2b) . A strong eect was observed in HPV1 and 16 HA-E7 expressing cells, whilst a lower and intermediate rate of cell death was detected in cells infected with an empty control retrovirus or expressing HPV6 HA-E7 gene, respectively (Figure 2b ). However, analysis on agarose gel of the DNA isolated from the dierent cell lines reveals that only the DNA isolated from HPV1 and 16 E7 expressing cells clearly shows the characteristic DNA ladder (Figure 2c ), representing the internucleosomal cleavage that occurs during apoptosis. To exclude the possibility that the fusion of HA-tag to the E7 proteins could alter their functions, we have repeated the experiments with cells expressing the native E7 genes. In all cases the results obtained were similar (data not shown), showing that the HA-tag does not in¯uence the activity of the dierent E7 proteins in this assay.
Thus, the ability of the three E7 proteins to induce apoptosis appears to correlate with pocket proteins binding eciency. HPV6 E7, which associates only weakly with pRb, p107 and p130, is a weak inducer of apoptosis. HPV1 and 16 E7s bind with high anity the pocket proteins and eciently induce apoptosis. Moreover, our data show that the E7 ability to promote apoptosis is independent of its transforming activity. HPV1 E7 protein, in contrast to HPV16 E7, is not able to co-operate with activated ras in transforming primary cells in vitro (Ciccolini et al., 1994; Schmitt et al., 1994) , but is competent in inducing apoptosis.
pRb inactivation is an essential requirement for HPV16 E7-induced apoptosis
The comparative analysis of the three E7 proteins indicates that the eciency in binding pocket proteins correlates with the ability to induce apoptosis. However, it is not clear whether this event is mediated by The point mutations in conserved region 1 (CR1) and conserved region 2 (CR2) of HPV16 E7 are also shown simultaneous inactivation of pRb, p107 and p130 or by inactivation of one member only of the pocket protein family. To address this question, we took advantage of the fact that speci®c point mutations at the pocket protein binding domain in the HPV16 E7 conserved region 2 (CR2) dierently aect the interaction of the viral protein with pocket proteins. Four CR2 HPV16 E7 mutants, HPV16 E7 L22?A, C24?G, E26?Q and S31/32?A, were used (see Figure  1 and Table 2 ). Substitution of the amino acid in position 24 (C?G) is known to abrogate binding of E7 to any member of the pocket proteins (Davies et al., 1993) . In contrast, a HPV16 E7 mutant harbouring a point mutation at position 26 (E?Q) is still able to associate with p107 (Davies et al., 1993) and p130 (data not shown), but does not interact with pRb (Davies et al., 1993) . Accordingly, the HPV16 E7 26 E?Q, but not the C24?G mutant, retains the ability to activate E2F inhibited by p107, as deduced from studies on the B-myb promoter (Lam et al., 1994) . The S31/32?A mutant, located immediately after the LXCXE motif, is defective for Casein Kinase II phosphorylation but is fully competent to associate with the pocket proteins (Barbosa et al., 1990) . Mutation of the ®rst amino acid of the pocket protein-binding doman (L22?A) in an analogous fashion to HPV16 E7 26 E?Q, abrogates the pRb interaction without any eect on the E7/p107 and E7/ p130 association (data not shown). The four mutants described above were fused to the HA epitope (Figure 1 ), cloned into the pBabe-puro vector and tested for their ability to stimulate apoptosis of NIH3T3 cells. After retroviral infection, the levels of each HPV16 HA-E7 mutant were determined by immunoblot analysis using a HA speci®c monoclonal antibody. As shown in Figure  3a , the HPV16 E7 wild type and the four CR2 mutants are expressed at similar levels. To determine the ability of the mutants to induce S phase and apoptosis, NIH3T3 cells were cultured in serum-deprived medium. None of the HPV16 E7 proteins with a mutated pocket proteinbinding domain was able to stimulate either DNA synthesis ( Figure 3b ) or apoptosis (Figure 3c, d) . In contrast, the E7 S31/32?A mutant, which retains the ability to bind pocket proteins, displays an activity similar to the wild type protein in the induction of S phase and apoptosis (Figure 3b ± d) . Since the three HPV16 E7 L22?A, C24?G and E26?Q mutants do not associate with pRb, our results indicate that pRb inactivation is an essential requirement for HPV16 E7-induced apoptosis. However, they do not exclude the possibility that inactivation of the other two pRb-related proteins, p107 and p130, also contributes to the induction of apoptosis. To investigate this possibility we expressed the HPV16 HA-E7 gene in immortalized mouse embryo ®broblasts lacking a functional pRb (MEF pRb 7/7
). As shown in Figure 4a , HPV16 HA-E7 induces apoptosis in serum-deprived MEF pRb +/+ . In contrast, in serum-deprived MEF pRb 7/7 , apoptosis was The DNA fragmentation, characteristic of the internucleosomal cleavage that occurs during apoptosis, was analysed on a 1.8% agarose gel. DNA was extracted from NIH3T3 cells expressing dierent E7 genes as described in Materials and methods Figure  4a , apoptosis was also induced by TNFa/cycloheximide treatment, which has been shown to promote apoptosis in primary human keratinocytes expressing HPV16 E7 gene (Iglesias et al., 1998) . HPV16 E7 protein sensitizes MEF pRb +/+ to apoptosis upon TNFa/cycloheximide treatment, whilst in MEF pRb 7/7 cells the percentage of apoptotic cells was similar in absence or presence of E7 protein (Figure 4b ). Thus, HPV16 E7 protein does not augment the induction of apoptosis in MEF pRb 7 / 7 . Taken together, these results indicate that inactivation of pRb by E7, but not p107 or p130, is required for the induction of apoptosis.
Stimulation of DNA synthesis is not sufficient to induce apoptosis
The analysis of the CR2 HPV16 E7 mutants suggests that the induction of apoptosis may be directly linked to the ability of E7 to drive ®broblasts into S phase. It was previously reported that a point mutation in the CR1 of HPV16 E7 (H2?P) aects its in vitro transforming activity without altering the ability to interact with pocket proteins and stimulate DNA synthesis (Banks et al., 1990b) . These data indicate that distinct pathways mediate the dierent E7 biological activities. In order to evaluate whether the induction of apoptosis is separated from the S phase stimulation, we have analysed the biological activities of the HPV16 E7 H2?P and two other CR1 mutants (L8?T and E10?Q). A previous study has proved that point mutations in amino acids 8 and 10 do not alter the in vitro transforming properties of HPV16 E7 (Phelps et al., 1992) . As a ®rst step, we determined the ability of the HPV16 E7 L8?T and E10?Q mutants to associate with pocket proteins in the GST pull-down assay. Similarly to the E7 H2?P mutant, the L8?T and E10?Q mutants retain the property to interact with pRb, p107 and p130 (Figure 5a and data not shown). Next, the E7 CR1 mutants were fused to the HA epitope (Figure 1) , cloned into the pBabe-puro vector and expressed in NIH3T3 cells. Western blot analysis of total cellular protein extracts shows that the three E7 proteins are expressed at approximately the same levels as HPV16 E7 wild type (Figure 5b ). To determine whether the HPV16 E7 CR1 mutants are able to drive NIH3T3 cells in S phase, cells were cultured in medium containing 0.5% CS for 48 h and the cell cycle pro®les were analysed by¯ow cytometry. All the three HPV16 E7 CR1 mutants are able to drive serum-deprived NIH3T3 cells into S phase (Figure 5c ). Next we determined the apoptosis in cells expressing the HPV16 E7 mutants by TUNEL staining or timelapse videomicroscopy. As shown in Figure 5d ,e, only the wild type or H2?P HPV16 E7 proteins induce apoptosis, whilst no signi®cant dierence was observed between cells expressing L8?T or E10?Q HPV16 E7 mutants and the control cells (Figure 5d,e) . Thus, the E7-induced apoptosis is not a direct consequence of the DNA synthesis stimulation. Therefore, these two E7-mediated cellular events are separable in NIH3T3 cells.
pRb destabilization is not required either for stimulation of DNA synthesis or apoptosis
Previous data have demonstrated that the association of HPV16 E7 with pRb promotes a rapid degradation of the pocket protein (Boyer et al., 1996; . To evaluate whether the E7-mediated pRb degradation is associated with the induction of S phase and/or apoptosis, we have determined the levels of pRb in cells expressing the dierent E7 proteins. First we analysed the pRb levels in cells expressing HPV1 and 16 E7 genes cultured in DMEM containing 0.5% CS for 48 h. The levels of pRb were determined by Western blot analysis. As shown in Figure 6a the levels of pRb are strongly decreased in HPV16 E7 expressing cells, whilst no signi®cant changes were observed in HPV1 E7 and control cells. Since HPV1 E7 sensitizes NIH3T3 cells to undergo apoptosis, these data indicate that degradation of pRb is not required for the induction of this event. These ®ndings were further corroborated by the use of the HPV16 E7 mutants. In Figure 6b it is shown that the amount of pRb is signi®cantly decreased in cells expressing HPV16 E7 wild type and the S31/32?A proteins. In particular, the levels of hypophosphorylated pRb, which is speci®c of G1 phase and is the only form targeted by HPV16 E7, are strongly reduced ( Figure  6b ). As previously reported, the CR2 HPV16 E7 mutant, S31/32?A, appears to have a weaker activity than the wild type in destabilizing pRb . Any of the other HPV16 E7 CR1 and CR2 mutants, do not promote destabilization of pRb ( Figure 6b) . Thus, as shown for HPV1 E7, the HPV16 E7 H2?P mutant does not destabilize pRb, but can eciently induce apoptosis (Figures 5d,e and 6b). Cells expressing the L22?A, C24?G and E26?Q mutants, which are unable to associate with pRb, have high levels of G1 speci®c hypophosphorylated pRb form (Figure 6b ). This is in agreement with the fact that the three HPV16 E7 mutants are not able to alleviate the G1 block imposed by serum deprivation. In contrast, cells expressing the three CR1 HPV16 E7 mutants, which induce S phase entry, have equal amounts of hypoand hyperphosphorylated pRb (Figure 6b ). Together these data show that the ability of E7 to induce S phase and apoptosis is independent of the ability to destabilize pRb. Furthermore, since it has been reported that the HPV16 E7 E10?Q mutant is fully competent in transforming primary rodent cells in cooperation with activated ras (Phelps et al., 1992) , we can conclude that the HPV16 E7 in vitro transforming activity is not associated with pRb degradation.
The E7-induced apoptosis in NIH3T3 is not associated with a p53 accumulation
The transcription of the p19 ARF gene is positively regulated by E2F-1 . Thus, it is likely that HPV16 E7 expression induces accumulation of p19 ARF via activation of E2F-1. The increased levels of p19 ARF lead to neutralization of Mdm2 and consequent stabilization of p53, which in turn can induce cell cycle arrest or trigger apoptosis (reviewed by Sherr, 1998) . In NIH3T3 cells the INK4a/ARF locus has sustained deletions and therefore the protein is not synthesized. A study in MEF lacking p19 ARF has demonstrated that HPV16 E7 is able to stabilize p53 through an alternative mechanism (Seavey et al., 1999) . In order to determine whether the E7-induced apoptosis in NIH3T3 is associated to an increased steady-state level of p53, we have determined the intracellular concentration of p53 in NIH3T3 cells infected with empty retrovirus or expressing HPV1, 6 and 16 HA-E7 genes. Quanti®cation of the p53 positive signal in immunoblotting, normalized to the tubulin signal (loading control), reveals that similar levels of p53 were detected in the control and HA-E7 expressing cells (Figure 7) . Thus, the E7-induced apoptosis in NIH3T3 is independent of the presence of p19 ARF and it does not require further increase of p53 levels.
Discussion
HPV16 infection normally results in a self-limiting benign proliferation. However, in a fraction of cases, the proliferative lesion, after a long latent period, progresses to malignancy. It is conceivable that the Figure 5 Ability of HPV16 E7 CR1 mutants to associate with the pocket proteins, to induce S phase and apoptosis. (a) The ability of the HPV16 HA-E7 H2?P, L8?T and E10?Q mutants to associate with pRb and p107 was tested in the GST pull-down assay. One mg of the dierent GST proteins were immobilized on Glutathione and incubated with 1 mg of NIH3T3 protein extract. After 1 h, the beads were extensively washed and directly resuspended in SDS-sample buer. The amount of pRb and p107 associated with the dierent GST/E7 proteins was determined by Western blot analysis using a speci®c anti pRb and p107 antibodies. One tenth of the total cellular extract (100 mg) used in the GST pull-down assay (input) was applied on a polyacrylamide-SDS gel. (b) The level of CR1 HPV16 HA-E7 mutants in NIH3T3 cells was determined by immunoblot. Fifty mg of protein extracts were applied on a 12% polyacrylamide-SDS gel, transferred to PVDF membranes and incubated with an anti HA-tag monoclonal antibody (MMS-101R, Babco, dilution 1 : 1000). Protein markers were obtained from Gibco. (c) The ability of the CR1 HPV16 HA-E7 mutants to stimulate S phase in quiescent cells was determined by FACS analysis. NIH3T3 cells were grown in DMEM containing 0.5% CS for 48 h, stained with propidium iodide and the percentage of each phase of the cell cycle was determined by¯ow cytometry. Similar results were obtained in three independent experiments. The ®gure shows the data of a representative experiment. (d) NIH3T3 cells expressing the dierent E7 genes as indicated in the ®gure were cultured in DMEM containing 0.5% CS for 48 h and the percentage of apoptotic cells were determined by TUNEL staining. Three hundred cells were counted for each staining. The data are the mean of two independent experiments. (e) NIH3T3 cells were infected with recombinant retroviruses as shown in the ®gure and cultured in DMEM containing 0.5% CS. Cellular death was monitored by time-lapse videomicroscopy for times indicated in the ®gure balance between proliferation and apoptosis plays a role in determining the progression or regression of the benign lesion. Indeed, interfering with such a balance by favouring apoptosis, may limit HPV-induced proliferation. Thus, understanding the mechanism by which E6 and E7 proteins aect apoptotic pathways is essential. In this study we have analysed the ability of dierent E7 proteins to promote apoptosis in immortalized rodent ®broblasts. Our data demonstrate that E7-induced apoptosis is tightly associated with the neutralization of pRb functions, since inactivation of two other members of the pocket protein family, p107 and p130, by the L22?A and E26?Q HPV16 E7 mutants, is not sucient to promote apoptosis. Furthermore, in mouse embryo ®broblasts lacking a functional pRb, the presence of HPV16 E7 does not increase the percentage of apoptotic cells.
Using two transforming de®cient HPV16 E7 mutants, D6 ± 10 and D21 ± 24, Jones and MuÈ nger (1997) provided evidence that both CR1 and CR2 are essential for the induction of apoptosis and destabilization of pRb. Based on these ®ndings they concluded that the ability of HPV16 E7 to induce destabilization of pRb and apoptosis coincides with E7-mediated transformation . Our data are in agreement with the fact that induction of apoptosis by HPV16 E7 is mediated by two distinct functions of CR1 and CR2. However, here we show that the ability of E7 proteins to trigger apoptosis is independent of the ability to induce transformation and degradation of pRb. HPV1 E7 and HPV16 E7 H2?P are not able to co-operate with activated ras in the transformation of primary cells in vitro (Banks et al., 1990a; Ciccolini et al., 1994; Schmitt et al., 1994) and to destabilize pRb, but are fully competent in promoting apoptosis. Furthermore, a CR1 mutant of HPV16 E7 (E10?Q) retains the property to in vitro transform primary cells (Phelps et al., 1992) and we observed that it is unable to induce apoptosis and pRb destabilization.
Adenovirus E1A, a structurally and functionally E7-related protein, is also able to sensitize cells to apoptosis (Querido et al., 1997; Samuelson and Lowe, 1997; Shisler et al., 1996) . Although E1A and E7 promote apoptosis via the same domains, CR1 and CR2, their mechanisms appear to be dierent. In E1A-induced apoptosis, two independent activities of the viral protein act in concert. The ®rst is located in the CR1 and correlates with the ability of E1A to associate with transcriptional co-activators p300 and CBP (for review see Flint and Shenk, 1997) and, with low anity, with pRb. The second is located in the CR2 and is mediated by the LXCXE motif, which binds pRb with high anity (Samuelson and Lowe, 1997) . Since these two functions can act independently, E1A CR1 or CR2 mutants partially retain the ability to induce apoptosis (Samuelson and Lowe, 1997) . In contrast, HPV16 E7 CR1 (L8?T or 10E?Q) and CR2 mutants are inactive in promoting apoptosis. These ®ndings indicate that in HPV16 E7 the CR1 and CR2 activities cannot act independently. One possible explanation is that an intact CR2 is required to target CR1 to the pRb complex in order to exert its activity. We can speculate that CR1 alters the function of pRbassociated proteins, which are not displaced by E7 binding, e.g. the c-Abl tyrosine kinase (Welch and Wang, 1993) . Thus, it is possible that the HPV16 E7 CR1 promotes apoptosis by altering the c-Abl functions, even if it is still associated with pRb. Interestingly, it has been recently shown that c-Abl promotes apoptosis independently of p53, which can be partially overcome by pRb (Theis and Roemer, 1998) In this study, we also show that the ability of E7 protein to stimulate DNA synthesis in quiescent cells can be dissociated from its ability to promote apoptosis in NIH3T3 cells. Two CR1 HPV16 E7 mutants (L8?T and E10?Q) do not induce apoptosis, although both Figure 6 Ability of the E7 proteins to induce destabilization of pRb. The level of pRb was determined in NIH3T3 cells expressing the dierent E7 genes as indicated in a and b. Fifty mg of protein extracts were fractionated on a 8% polyacrylamide-SDS gel, transferred to PVDF membranes and incubated with speci®c antibodies for pRb or tubulin. Tubulin signal was used as loading control Figure 7 The E7 expression does not lead to a p53 accumulation in NIH3T3. The levels of p53 were determined by immunoblot analysis. Fifty mg of protein extracts were applied on a 10% polyacrylamide-SDS gel, transferred to PVDF membranes and incubated with speci®c antibodies for tubulin and p53. Tubulin signal was used as loading control retain the ability to stimulate DNA synthesis. Together these data indicate that the CR1 function in promoting apoptosis is independent of the activation E2F1-driven transcription. In support of this model, it was recently shown that E7-induced apoptosis in neonatal lens of the mouse eye is partially independent of E2F-1 activation (McCarey et al., 1999) .
Studies on Adenovirus E1A have demonstrated that the induction of apoptosis is mediated by p19 ARF with consequent stabilization of p53 (de Stanchina et al., 1998; Lowe and Ruley, 1993) . Our ®ndings demonstrate that the expression of E7 proteins does not lead to an accumulation of p53 in NIH3T3 cells, which do not express p19 ARF . These ®ndings propose that in these cells p53-independent pathways may mediate the E7-induced apoptosis. Alternatively, we can hypothesize that the E7-induced apoptosis is dependent on p53 and that its levels in NIH3T3 are suciently high to induce apoptosis in co-operation with cellular pathways targeted by E7 proteins.
In summary, we have demonstrated that the ability of HPV16 E7 to stimulate S phase in quiescent NIH3T3 cells requires the integrity of the CR2, whilst the ability to induce apoptosis requires both CR1 and CR2 functions. Although our data show that the S phase stimulation by E7 is not sucient to promote apoptosis, whether S phase entry is required for the E7-induced apoptosis remains to be elucidated.
Materials and methods

Retroviral expression vectors
The retroviral vector pBabe-puro was described previously (Morgenstern and Land, 1990) . ORF sequences corresponding to HPV 1E7, 6E7, 16E7 and 16E7 mutants were cloned into pBabe-puro. The Haemagglutinin tag (HA-tag) fusion proteins were generated by cloning E7 genes immediately downstream of the HA-tag sequence (see Figure 1) .
Cell culture and retroviral infections
BOSC23 and MEFs cells were cultured in Dulbecco's modi®ed Eagle's medium (DMEM) supplemented with 10% foetal calf serum (FCS) and NIH3T3 were cultured in DMEM supplemented with 10% calf serum (CS). High-titre recombinant retroviruses (55610 6 iu/ml) were generated by transient transfection of BOSC23 cells and used to infect NIH3T3 cells as described (Pear et al., 1993) . NIH3T3 and MEFs cells were infected for 48 h with the retroviral supernatants and then selected with puromycin (Sigma, 2.5 mg/ml). To avoid the possibility of chromosomal instability due to in vitro manipulation, the experiments described here were performed with cells, which were not cultured for more than six passages.
In NIH3T3 apoptosis was induced by culturing the cells in DMEM containing 0.5% CS for the times indicated for each experiment, whilst in immortalized MEF by culturing the cells in DMEM containing 0.5% FCS, or by TNFa/ cycloheximide treatment for 24 h (500 units/ml and 10 mg/ ml, respectively).
Detection of apoptosis
Apoptosis in NIH3T3 cells induced by HPV16 E7 was analysed by three dierent methods: (a) Apoptosis Detection System, Fluorescein (Promega), performed according to the manufacturer's instructions. This assay allows detection of the fragmented DNA of apoptotic cells by catalytically incorporating¯uorescein-12-dUTP* at the 3-OH DNA ends using the enzyme Terminal deoxynucleotidyl Transferase (TdT). The¯uorescein-12-dUTP-labelled DNA was visualized directly by¯uorescence microscopy; (b) NIH3T3 cells expressing the dierent E7 genes were seeded and cultured in 0.5% CS for 96 h. Attached and¯oating cells were harvested and washed twice with ice-cold PBS. The cell pellet was resuspended in 100 ml lysis buer (20 mM HEPES, pH 7.2, 5 mM KCl, 1 mM MgCl 2 , 0.5% NP40, 0.1% sodium deoxycolate, 10 mM EDTA) and incubated on ice for 10 min. The lysate was treated with 50 mg of proteinase K for 1 h on ice and then extracted three times with phenol : chloroform and once with chloroform alone. DNA was recovered by precipitation in ethanol in the presence of 0.3 M Sodium Acetate, pH 5.2 and resuspended in TE containing 10 mg/ml of RNase A. DNA was then analysed by gel electrophoresis on a 1.8% agarose gel; (c) time-lapse videomicroscopy was performed and the apoptotic events analysed as previously described (Evan et al., 1992) .
FACS analysis
NIH3T3 cells infected with dierent recombinant retroviruses were seeded and cultured in 0.5% CS for 48 h. Cells (10 cm plate, 80% con¯uence) were harvested by trypsinization, washed with PBS and ®xed in 80% methanol at 7208C for 30 min. 10 6 cells were washed in PBS, and resuspended in 500 ml of PBS containing RNase A (0.1 mg/ml). After incubation (30 min at 378C), propidium iodide was added (5 ml of a 50 mg/ml solution). Analysis by¯ow cytometry was performed with a Becton Dickinson FACSort. Cell cycle pro®les were determined by using the Mod®t cell analysis software package.
Cell extract preparation, antibodies and Western blotting
Total cellular extracts were prepared from NIH3T3 cells (15 cm plate, 80% con¯uence) as described in (Tommasino et al., 1993) . Fifty mg of total extract was precipitated in acetone (9 : 1/v/v 20 min at 7208C, centrifuged (12 000 g, 10 min) and resuspended in 20 ml of gel loading buer. Total cell extracts were fractionated by electrophoresis on a polyacrylamide gel containing 0.1% SDS. Proteins were transferred onto a Polyscreen PVDF transfer membrane (DuPont) in a Trans-Blot semidry electrophoretic transfer cell (Bio-Rad). Immunocomplexes were detected with ECL reagent (Amersham). The following antibodies were used: MMS-101R (Babco, dilution 1 : 1000) against E7 proteins tagged with HA epitope; 14001A (Pharmingen, dilution 1 : 1000) against pRb; C-18 (Santa-Cruz, dilution 1 : 1000) against p107; Ab-5 (Oncogene Science, dilution 1 : 500) against p53, TUB2.1 (Sigma, dilution 1 : 1000) against b-tubulin.
GST-pull down assay
Wild type and mutants HPV16 E7 genes were cloned in pGEX fused in frame to the carboxy-terminal sequence of the Schistosoma japonicum glutathione S-transferase (GST) and expressed in bacteria. The recombinant GST/E7 fusion proteins were synthesized in E. coli DH5a strain and puri®ed by single step chromatography on Glutathione-Sepharose. Approximately 1 mg of GST/E7 proteins immobilized on Glutathione beads were used for in vitro pull-down assay. The E7s beads were mixed with 1 mg of NIH3T3 extract and incubated for 1 h under rotation. After extensive washings in NETN buer (20 mM Tris-HCl pH 8.0, 1 mM EDTA, 100 mM NaCl, 0.5% Nonidet 40), beads were resuspended in SDS-sample buer and soluble proteins were applied to SDS-polyacrylamide gels, transferred to PVDF membrane (DuPont) and reacted with antibodies raised against pRb and p107.
